药品名称HYPAQUE-M,75%
申请号010220产品号003
活性成分DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM市场状态停止上市
剂型或给药途径INJECTABLE;INJECTION规格50%;25%
治疗等效代码参比药物
批准日期Approved Prior to Jan 1, 1982申请机构GE HEALTHCARE
化学类型New formulation or new manufacturer审评分类Standard review drug
与本品相关的专利信息(来自橙皮书Orange Book)
专利号专利过期日是否化合物专利是否产品专利专利用途代码专利下载
历史专利信息
与本品相关的市场独占权保护信息
独占权代码失效日期
历史市场独占权保护信息
与药品注册相关的信息
申请号修订号审批结论公开文档类型文档创建时间获取文档
药品注册审批历史信息
申请号修订号审批结论审批日期审批内容
010220046AP1994/03/25Manufacturing Change or Addition
010220045AP1990/09/04Labeling Revision
010220044AP1991/10/03Labeling Revision
010220043AP1991/04/24Control Supplement
010220042AP1989/06/28Labeling Revision
010220041AP1989/05/19Labeling Revision
010220040AP1989/04/11Manufacturing Change or Addition
010220039AP1990/02/26Manufacturing Change or Addition
010220038AP1986/06/25Labeling Revision
010220037AP1986/06/25Labeling Revision
010220036AP1985/07/24Labeling Revision
010220035AP1985/06/26Labeling Revision
010220034AP1984/09/13Labeling Revision
010220033AP1988/05/23Package Change
010220032AP1983/11/30Package Change
010220031AP1983/02/28Control Supplement
010220030AP1984/08/07Practioner Draft Labeling
010220029AP1979/02/17Manufacturing Change or Addition
010220028AP1978/03/31Labeling Revision
010220027AP1978/02/01Control Supplement
010220026AP1978/02/01Manufacturing Change or Addition
010220025AP1978/03/31Labeling Revision
010220024AP1976/04/08Labeling Revision
010220023AP1976/01/26Labeling Revision
010220022AP1976/01/21Labeling Revision
010220021AP1976/01/21Supplement
010220017AP1974/01/29Labeling Revision
010220000AP1955/11/09Approval